A better band-aid: New 'suspended animation' technology could revolutionize wound care
ÍÃ×ÓÏÈÉú´«Ã½ÎÄ»¯×÷Æ· Today—ÍÃ×ÓÏÈÉú´«Ã½ÎÄ»¯×÷Æ· researchers led by Professors Christopher Bowman and Kristi Anseth have received up to $5.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a new wound treatment that temporarily halts cellular activity to prevent tissue damage. Inspired by the biostasis of tardigrades, the light-activated hydrogel could one day protect and preserve tissue in burns, frostbite and battlefield injuries.
Partnering Opportunities for CU Bioscience Technologies
Biosciences are crucial for advancing medical knowledge and improving patient care. At the University of Colorado, cutting-edge research in these fields is driving significant breakthroughs. The university's advanced facilities and collaborative environment enable researchers to delve into areas such as molecular medicine, regenerative therapies and personalized healthcare. By translating scientific discoveries into innovative treatments and technologies, CU is at the forefront of improving health outcomes and enhancing the quality of life for people around the world.
Ìý
The Newsroom
For marketing and communication inquiries or news tips, contact Daniel Leonard,Ìýsenior marketing and communications specialist for Venture Partners at ÍÃ×ÓÏÈÉú´«Ã½ÎÄ»¯×÷Æ·.
For media inquiries, please visit .